CVS Health Corp (CVS)

75.70
-0.07 (-0.09%)
NYSE · Last Trade: Feb 10th, 10:16 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
CVS Health Navigates a Stormy 2026: Record Revenue Tempered by Medicare Advantage Costs and PBM Turmoil
In a pivotal earnings report delivered on February 10, 2026, CVS Health (NYSE: CVS) showcased a complex narrative of financial resilience and operational headwinds. While the healthcare giant posted record-breaking revenue of $402.1 billion for the full year 2025, surpassing Wall Street expectations, its stock dipped nearly 2.5%
Via MarketMinute · February 10, 2026
CVS Health (NYSE:CVS) Surprises With Q4 CY2025 Sales
Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.2% year on year to $105.7 billion. Its non-GAAP profit of $1.09 per share was 9.4% above analysts’ consensus estimates.
Via StockStory · February 10, 2026
CVS Health Corp (NYSE:CVS) Beats Q4 Estimates but Shares Dip on Cautious Outlookchartmill.com
Via Chartmill · February 10, 2026
Landmark Settlement: The Cigna Group Resolves FTC Insulin Pricing Suit, Reshaping the PBM Landscape
In a move that marks a definitive shift in the American pharmaceutical supply chain, The Cigna Group (NYSE: CI) has reached a comprehensive settlement with the Federal Trade Commission (FTC) to resolve a contentious lawsuit regarding the pricing of insulin. Announced in early February 2026, the agreement effectively ends years
Via MarketMinute · February 9, 2026
The Future of a Healthcare Titan: UnitedHealth Group (UNH) at a Regulatory Crossroads
The healthcare landscape in early 2026 is defined by a shift from unrestrained growth to tactical consolidation. At the center of this transition sits UnitedHealth Group (NYSE: UNH), a behemoth that has navigated a tumultuous 24 months marked by massive cyber-disruptions, leadership overhauls, and intensifying federal scrutiny. Today, February 9, 2026, the company finds itself [...]
Via Finterra · February 9, 2026
CVS Health (CVS) Q4 Earnings: What To Expect
Diversified healthcare company CVS Health (NYSE:CVS) will be announcing earnings results this Tuesday morning. Here’s what to expect.
Via StockStory · February 8, 2026
Should You Buy CVS Health Stock Before Feb. 10?fool.com
Recent Medicare Advantage news may mean disappointing updates to guidance.
Via The Motley Fool · February 7, 2026
Molina Healthcare Shares Plunge 28% as 2026 Profit Outlook Crumbles Under Surging Medical Costs
The managed care sector was sent into a tailspin on Friday as Molina Healthcare (NYSE: MOH) saw its market capitalization evaporate in a historic sell-off. Shares of the Long Beach-based insurer plummeted 28% to $127.16 after the company issued a 2026 earnings forecast that was not just a miss,
Via MarketMinute · February 6, 2026
Fiscal Brinkmanship: Data Blackout and the DHS Cliff Loom Over Markets After Narrow Funding Deal
In a week defined by high-stakes political theater and a brief but disruptive lapse in federal operations, Washington has managed to pull back from the edge of a total collapse—though only partially. On February 3, 2026, a $1.2 trillion appropriations package was signed into law, ending a four-day
Via MarketMinute · February 6, 2026
Is CVS Health Stock a Bad-News Buy?fool.com
Medicare Advantage rates may not be going up as much as expected in 2027, and that has investors concerned about CVS Health.
Via The Motley Fool · February 5, 2026
Should You Buy UnitedHealth Group Stock After Its Steep Sell-Off?fool.com
Tuesday's sell-off in UnitedHealth Group's stock was arguably overdone.
Via The Motley Fool · January 29, 2026
S&P 500 Shatters Historic 7,000 Milestone as AI Supercycle and Fiscal Stimulus Fuel New Market Era
Wall Street reached a monumental psychological and financial peak on Wednesday as the S&P 500 index briefly eclipsed and then closed near the 7,000-point mark for the first time in history. This breakthrough, occurring on January 28, 2026, represents a staggering 16.6% climb from the 6,000-point
Via MarketMinute · January 28, 2026
UnitedHealth Group Shares Crater 20% as CMS Shocks Market with Near-Zero Medicare Rate Increase for 2027
In a historic blow to the managed care sector, UnitedHealth Group (NYSE: UNH) saw its stock price plunge nearly 20% on Tuesday, marking its worst single-day performance in over three decades. The massive selloff, which erased approximately $80 billion in market value, was triggered by a surprisingly lean 2027 Advance
Via MarketMinute · January 28, 2026
Elevance Health (ELV) Deep-Dive: Navigating the 2026 Regulatory Storm and the Carelon Transformation
Today’s Date: January 28, 2026 Introduction Elevance Health, Inc. (NYSE: ELV) stands at a critical crossroads in the healthcare landscape of 2026. Once known primarily as a regional Blue Cross Blue Shield insurer, the company has transformed into a diversified health services behemoth. However, as of late January 2026, the company is navigating one of [...]
Via Finterra · January 28, 2026
The CVS Turnaround: A 2026 Deep-Dive into the Future of Integrated Healthcare
This content is intended for informational purposes only and is not financial advice. Introduction As of January 28, 2026, CVS Health Corporation (NYSE: CVS) stands as a case study in corporate resilience and strategic pivot. After a tumultuous 2024 that saw the healthcare titan lose nearly 40% of its market capitalization due to Medicare Advantage [...]
Via Finterra · January 28, 2026
Humana Inc. (HUM): Navigating the Medicare Advantage Reset
Date: January 28, 2026 The landscape of American managed care is currently undergoing a seismic shift, and perhaps no company exemplifies this transformation—and the accompanying volatility—more than Humana Inc. (NYSE: HUM). Long considered the "pure-play" leader in Medicare Advantage (MA), Humana finds itself at a critical juncture. As of today, January 28, 2026, the company [...]
Via Finterra · January 28, 2026
Tech Floats the Index While Health Care Springs a Leakchartmill.com
Via Chartmill · January 28, 2026
3 S&P 500 Stocks We’re Skeptical Of
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Via StockStory · January 27, 2026
Spotting Winners: Alignment Healthcare (NASDAQ:ALHC) And Health Insurance Providers Stocks In Q3
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Alignment Healthcare (NASDAQ:ALHC) and its peers.
Via StockStory · January 27, 2026
Corporate Bonds vs. Treasuries: What Your Defensive Allocation Is Built Onfool.com
Both Vanguard Short-Term Corporate Bond ETF and Vanguard Short-Term Treasury ETF aim to steady a portfolio. This article looks at where that stability comes from, and why the difference shows up when credit conditions change.
Via The Motley Fool · January 27, 2026
Why CVS Health (CVS) Shares Are Plunging Today
Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 13.9% in the afternoon session after the Centers for Medicare and Medicaid Services (CMS) proposed a significantly lower-than-expected payment rate increase for Medicare Advantage plans in 2027. 
Via StockStory · January 27, 2026
Rate Shock: 2027 Medicare Advantage Proposals Trigger $80 Billion Sell-Off in Managed Care
The healthcare sector was rocked this week as the Centers for Medicare & Medicaid Services (CMS) released its highly anticipated 2027 Advance Notice, proposing a base payment rate increase that fell staggeringly short of industry expectations. The announcement has sent major insurers into a tailspin, erasing approximately $80 billion in market
Via MarketMinute · January 27, 2026
Medicare Shock: UnitedHealth Plummets 19% as Trump Administration Tightens Reins on Private Medicare
The Dow Jones Industrial Average faced a significant headwind today, as shares of UnitedHealth Group (NYSE: UNH) experienced their worst single-day sell-off in over three decades. The collapse, which wiped out approximately $60 billion in market value, followed the Trump administration’s proposal of a nearly flat payment rate for
Via MarketMinute · January 27, 2026
What's going on in today's session: S&P500 moverschartmill.com
Via Chartmill · January 27, 2026
S&P 500 Hits Record Highs as Tech Earnings Ignite Market Rally
The U.S. stock market reached a historic milestone on January 27, 2026, as the S&P 500 (NYSEARCA:SPY) climbed to a fresh all-time high of 6,980.75, tantalizingly close to the psychologically significant 7,000 level. Driven by a surge in the Nasdaq Composite (NASDAQ:QQQ), which
Via MarketMinute · January 27, 2026